kartoun commited on
Commit
d395928
·
verified ·
1 Parent(s): f6e1d79

Update README.md

Browse files
Files changed (1) hide show
  1. README.md +163 -16
README.md CHANGED
@@ -1,20 +1,167 @@
1
  ---
2
  license: cc-by-4.0
 
 
 
3
  language:
4
- - en
5
  tags:
6
- - oligonucleotide
7
- - toxicity
8
- - hepatotoxicity
9
- - synthetic-data
10
- - siRNA
11
- - antisense-oligonucleotide
12
- - GalNAc
13
- - RNAi
14
- - ASO
15
- - drug-safety
16
- - tabular
17
- task_categories:
18
- - tabular-classification
19
- - tabular-regression
20
- ---
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
  ---
2
  license: cc-by-4.0
3
+ task_categories:
4
+ - tabular-classification
5
+ - tabular-regression
6
  language:
7
+ - en
8
  tags:
9
+ - oligonucleotide
10
+ - hepatotoxicity
11
+ - antisense
12
+ - siRNA
13
+ - GalNAc
14
+ - in-silico
15
+ - synthetic
16
+ - toxicology
17
+ - liver
18
+ size_categories:
19
+ - 10K<n<100K
20
+ ---
21
+
22
+ # OligoTox Phase 2 Dataset
23
+
24
+ A computationally generated, AI-ready, literature-informed dataset for
25
+ modeling oligonucleotide-associated hepatotoxicity. Released by DBbun
26
+ LLC as part of a submission to the NIH/NCATS OligoTox Open Data Challenge
27
+ Phase 2.
28
+
29
+ ## Summary
30
+
31
+ The dataset connects oligonucleotide sequence, chemical modification
32
+ pattern, delivery platform, dose/exposure context, in vitro or
33
+ translational liver-relevant assay context, controls, and toxicity
34
+ readouts in a structured set of tables. The final dataset contains:
35
+
36
+ - **1,120 oligo records** (1,000 generated non-control oligos + 120 controls)
37
+ - **5,600 assay instances** across multiple time points and replicates
38
+ - **16,800 replicate-level toxicity readouts**
39
+ - **128 tables** including 8 core modeling tables (oligo metadata, modifications, position-level modifications, biophysical, dose, assays, readouts, controls) plus per-source
40
+ evidence modules and supporting metadata files
41
+
42
+ The dataset is intended for use in developing, training, benchmarking,
43
+ and stress-testing in silico predictive models of oligonucleotide
44
+ toxicity. It is not presented as experimentally measured wet-lab data;
45
+ all values are computationally generated, with row-level provenance
46
+ metadata distinguishing literature-grounded generated values from
47
+ inferred and reported values.
48
+
49
+ ## How to use
50
+
51
+ ```python
52
+ import pandas as pd
53
+
54
+ # Core modeling tables
55
+ oligos = pd.read_csv("oligos.csv")
56
+ mods = pd.read_csv("chemical_modifications.csv")
57
+ biophys = pd.read_csv("biophysical_properties.csv")
58
+ dose = pd.read_csv("dose_exposure.csv")
59
+ assays = pd.read_csv("assays.csv")
60
+ readouts = pd.read_csv("toxicity_readouts.csv")
61
+ controls = pd.read_csv("controls.csv")
62
+
63
+ # Join into a model-ready table
64
+ model_ready = (readouts
65
+ .merge(assays, on="assay_id")
66
+ .merge(oligos, on="oligo_id")
67
+ .merge(mods, on="oligo_id")
68
+ .merge(biophys, on="oligo_id")
69
+ .merge(dose, on="oligo_id"))
70
+ ```
71
+
72
+ A baseline RandomForest classifier on standard predictors achieves
73
+ overall accuracy of approximately 0.84 on the calibrated dataset, with
74
+ per-class F1 scores of 0.95 (low-risk), 0.74 (moderate), and 0.49
75
+ (high-risk).
76
+
77
+ ## Dataset structure
78
+
79
+ ### Core modeling tables
80
+
81
+ | Table | Description |
82
+ |-------|-------------|
83
+ | `oligos.csv` | Oligonucleotide identifiers, target genes, modality, 5'-to-3' sequence, sequence length, control assignment, source role |
84
+ | `chemical_modifications.csv` | Aggregate chemistry per oligo: sugar chemistry, backbone class, phosphorothioate fraction, modification pattern, GalNAc conjugation, purity, characterization-method metadata |
85
+ | `oligo_modification_positions.csv` | **Position-level** chemical modifications: per-position base, sugar modification, backbone linkage, region (e.g., gapmer wing/gap, siRNA seed region), terminal conjugate, and provenance |
86
+ | `biophysical_properties.csv` | Predicted Tm, ΔG, GC content, off-target hybridization burden, sequence-derived risk fields |
87
+ | `dose_exposure.csv` | Dose/concentration, exposure duration, treatment frequency, exposure normalization |
88
+ | `assays.csv` | Model system, cell model, species/human-proxy flag, organoid/MPS status, replicate count, assay type |
89
+ | `toxicity_readouts.csv` | Replicate-level readouts: viability, ALT/AST proxy fold change, apoptosis, stress response, transcriptomic perturbation, immune activation, inflammatory context, overall risk score, hepatotoxicity label |
90
+ | `controls.csv` | Positive, negative, vehicle, and platform-specific control oligos with rationale, derived from public literature |
91
+
92
+ ### Supporting documentation tables
93
+
94
+ | File | Description |
95
+ |------|-------------|
96
+ | `schema.json` | Programmatic schema describing every table, column types, value ranges, and categorical values |
97
+ | `data_dictionary.csv` | Curated variable-level definitions for the core modeling tables |
98
+ | `data_dictionary_full.csv` | Auto-generated comprehensive column-level documentation across all dataset tables |
99
+ | `dataset_manifest.json` | Full inventory of dataset files with sizes |
100
+ | `reproducibility_manifest.json` | Reproducibility configuration: pipeline parameters, seeds, calibration step description |
101
+ | `validation_summary.csv` | Automated validation checks: row counts, identifier mapping, range checks, schema consistency |
102
+ | `assumptions.csv` | Explicit list of biological and modeling assumptions |
103
+ | `provenance.csv` | Provenance category definitions |
104
+ | `sources.csv` | Literature source metadata: paper titles, source IDs, relevance, license |
105
+ | `source_triage_log.csv` | Documentation of source-level inclusion, deferral, exclusion decisions |
106
+ | `information_gap_map.csv` | Identification of fields where future experimental data would have highest value |
107
+ | `model_readiness_report.csv` | Modeling-readiness summary across required predictor and outcome fields |
108
+ | `challenge_alignment_scorecard.csv` | Mapping of dataset components to challenge judging factors |
109
+ | `toxicity_readouts_calibration_audit.json` | Full specification of the stochastic readout calibration step (random seed, per-readout sigmas, score weights, label fractions) |
110
+ | `figures/` | Five reference figures: label distribution before/after calibration, classifier performance, risk score distribution, predictor distributions, top source contributors |
111
+
112
+ ### Per-source evidence modules
113
+
114
+ The dataset includes per-paper or per-context evidence tables (e.g.,
115
+ `hsd17b13_genetics_aso_translation.csv`, `pnpla3_azd2693_precision_mash.csv`,
116
+ `galnac_sirna_offtarget_rat_hepatotoxicity.csv`) that record the
117
+ literature-grounded generation logic applied for each source. These
118
+ tables document which design rationale, control logic, or readout
119
+ constraint was contributed by each source.
120
+
121
+ ## Provenance
122
+
123
+ Every generated value carries a provenance label, which can take one of
124
+ five values:
125
+
126
+ - `reported_in_paper` — value reported directly in a source paper
127
+ - `extracted_from_paper` — value extracted from a source paper's tables/figures
128
+ - `inferred_from_paper` — value inferred from source-level reasoning
129
+ - `literature_grounded_generated` — value generated within
130
+ literature-informed bounds
131
+ - `not_reported` — value not available
132
+
133
+ Toxicity readouts are stochastically calibrated with assay-specific
134
+ noise to produce realistic predictive structure for in silico modeling.
135
+ The full calibration specification is recorded in
136
+ `toxicity_readouts_calibration_audit.json`.
137
+
138
+ ## Limitations
139
+
140
+ - This dataset is computationally generated; no physical oligonucleotides
141
+ were synthesized, purified, administered, or assayed.
142
+ - The dataset is intended for in silico model development, schema
143
+ evaluation, and benchmarking. It is not intended as direct evidence
144
+ for regulatory decision-making.
145
+ - The hepatotoxicity label distribution (60% low / 30% moderate / 10%
146
+ high) is a deliberate benchmark stratification chosen to produce a
147
+ non-trivial classification problem with both common and rare strata;
148
+ it is not a claim about wet-lab oligonucleotide toxicity prevalence.
149
+ - Original source PDFs are not redistributed; sources are identified
150
+ through title-level metadata only.
151
+
152
+ ## Citation
153
+
154
+ If you use this dataset, please cite:
155
+
156
+ ```
157
+ DBbun LLC. OligoTox Phase 2 Dataset: A computationally generated,
158
+ literature-informed dataset for oligonucleotide-associated hepatotoxicity
159
+ modeling. Hugging Face Datasets, 2026.
160
+ ```
161
+
162
+ ## Related work
163
+
164
+ DBbun LLC has previously released open synthetic biomedical datasets
165
+ including the MELD-Plus 1M cohort, the UK Biobank ASCVD 10M cohort, and
166
+ the Insomnia 1M cohort, all available under the DBbun namespace on
167
+ Hugging Face.